Stephen A. BaratPhD
Stephen A. Barat, PhD is Vice-President of Research and Early Clinical Development at Scynexis, a NJ-based biotechnology company focused on the development of novel treatments for serious and life-threatening infections. Prior to joining Scynexis, Dr. Barat held a series of positions of increasing responsibility with Allergan, Forest Laboratories and Schering-Plough. He has more than 20 years of experience in global drug development and registration, and is an internationally-recognized speaker on the subject of drug development and CMC-related safety assessment issues. Dr. Barat is a member of the PQRI PODP working group for leachables and extractables and the USP Expert Panel for Biocompatibility of Packaging Materials.